Neurocrine Biosciences (NBIX) and Abbott Labs (ABT) announce a global agreement to develop and...

|About: Neurocrine Biosciences, Inc. (NBIX)|By:, SA News Editor

Neurocrine Biosciences (NBIX) and Abbott Labs (ABT) announce a global agreement to develop and commercialize elagolix for treatment of endometriosis. NBIX shares +14.3%, ABT -0.2% premarket. (PR)